HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VISEN PHARMA-B

45.300

+0.2800.62%

Volume:6.00K

Turnover:272.87K

Market Cap:5.16B

PE:-23.28

High:45.980

Open:45.020

Low:45.020

Close:45.020

52wk High:69.150

52wk Low:39.250

Shares:114.00M

HK Float Shares:114.00M

Volume Ratio:0.63

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.946

ROE:-57.66%

ROA:-29.52%

PB:19.55

PE(LYR):-23.28

PS:1698.95

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Visen Pharmaceuticals Expands Supply Agreement with Ascendis Group for Broader Product Access

VISEN Pharmaceuticals' H1 Loss Widens 41%

MT Newswires Live

BRIEF-Visen Pharmaceuticals Logs HY Loss RMB118 Mln

Visen Pharmaceuticals Reports Increased Loss of RMB 118 Million for H1 2025; R&D and Administrative Expenses Rise Significantly

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02561"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02561","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"VISEN PHARMA-B","latestPrice":45.3,"timestamp":1757404707997,"preClose":45.02,"halted":0,"volume":6000,"delay":0,"floatShares":113999999,"shares":113999999,"eps":-1.946273,"marketStatus":"Closed","change":0.28,"latestTime":"09-09 15:58:27","open":45.02,"high":45.98,"low":45.02,"amount":272866,"amplitude":0.021324,"askPrice":45.52,"askSize":200,"bidPrice":45.28,"bidSize":700,"shortable":0,"etf":0,"ttmEps":-1.946273,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":5,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":45.02,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"volumeRatio":0.628931,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","floatShares":113999999,"roa":"-29.52%","roe":"-57.66%","lyrEps":-1.946273,"volumeRatio":0.628931,"shares":113999999,"dividePrice":0,"high":45.98,"amplitude":0.021324,"preClose":45.02,"low":45.02,"week52Low":39.25,"pbRate":"19.55","psRate":"1698.95","week52High":69.15,"institutionHeld":0,"latestPrice":45.3,"committee":0.555556,"eps":-1.946273,"divideRate":0,"volume":6000,"delay":0,"ttmEps":-1.946273,"open":45.02,"prevYearClose":68.8,"prevWeekClose":45.28,"prevMonthClose":45.68,"prevQuarterClose":45.3,"fiveDayClose":44.8,"twentyDayClose":48.9,"sixtyDayClose":53.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02561\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02561\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02561\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1746288000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02561\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02561","date":"2025-09-08","current":-23.637534,"percent":0.908257,"low":-30.760225,"twenty":-28.092535,"median":-27.098554,"eighty":-25.818169,"high":-17.514985,"avg":-26.59862,"sd":2.430211,"marketCap":4708478107},"quantilePoints":[{"date":"2025-04-03","current":-21.475965,"twenty":-22.637245,"median":-22.569747,"eighty":-22.098421,"marketCap":5724824916},{"date":"2025-04-11","current":-18.134639,"twenty":-22.558476,"median":-18.349759,"eighty":-18.045823,"marketCap":4802017317},{"date":"2025-04-17","current":-25.787715,"twenty":-25.955056,"median":-22.513392,"eighty":-18.141011,"marketCap":4682394110},{"date":"2025-04-25","current":-29.965674,"twenty":-27.695216,"median":-22.653961,"eighty":-18.190408,"marketCap":5445704099},{"date":"2025-05-02","current":-28.244363,"twenty":-27.861811,"median":-26.066617,"eighty":-18.349759,"marketCap":5143797909},{"date":"2025-05-09","current":-27.581562,"twenty":-28.248468,"median":-27.028836,"eighty":-20.850724,"marketCap":5058352761},{"date":"2025-05-16","current":-27.481285,"twenty":-28.307048,"median":-27.470681,"eighty":-22.305907,"marketCap":5081138134},{"date":"2025-05-23","current":-29.180898,"twenty":-28.483617,"median":-27.481285,"eighty":-22.603559,"marketCap":5411526040},{"date":"2025-05-30","current":-27.585218,"twenty":-28.483617,"median":-27.495492,"eighty":-22.648389,"marketCap":5138101566},{"date":"2025-06-06","current":-26.147365,"twenty":-28.307048,"median":-27.481285,"eighty":-24.987287,"marketCap":5212154028},{"date":"2025-06-13","current":-28.707887,"twenty":-28.307048,"median":-27.486097,"eighty":-25.744296,"marketCap":5724824916},{"date":"2025-06-20","current":-27.87701,"twenty":-28.483617,"median":-27.500076,"eighty":-26.010837,"marketCap":5548238276},{"date":"2025-06-27","current":-26.600431,"twenty":-28.46744,"median":-27.491566,"eighty":-26.131215,"marketCap":5308991862},{"date":"2025-07-04","current":-25.999842,"twenty":-28.345085,"median":-27.470681,"eighty":-26.039907,"marketCap":5189368655},{"date":"2025-07-11","current":-25.483255,"twenty":-28.252573,"median":-27.442177,"eighty":-25.700877,"marketCap":5081138134},{"date":"2025-07-18","current":-27.275886,"twenty":-28.168194,"median":-27.211053,"eighty":-25.700877,"marketCap":5434311412},{"date":"2025-07-25","current":-27.917728,"twenty":-28.10544,"median":-27.177054,"eighty":-25.808828,"marketCap":5582416336},{"date":"2025-08-01","current":-26.858726,"twenty":-28.252573,"median":-27.236899,"eighty":-25.835301,"marketCap":5337473578},{"date":"2025-08-08","current":-26.45431,"twenty":-28.168194,"median":-27.174901,"eighty":-25.937332,"marketCap":5270256728},{"date":"2025-08-15","current":-27.513449,"twenty":-28.142473,"median":-27.236899,"eighty":-26.012565,"marketCap":5473046546},{"date":"2025-08-22","current":-26.703746,"twenty":-28.118557,"median":-27.177054,"eighty":-26.021282,"marketCap":5295320638},{"date":"2025-08-29","current":-26.119434,"twenty":-28.10544,"median":-27.144467,"eighty":-26.021282,"marketCap":5204179147},{"date":"2025-09-05","current":-23.791598,"twenty":-28.093765,"median":-27.114576,"eighty":-25.835301,"marketCap":4735670561},{"date":"2025-09-08","current":-23.637534,"twenty":-28.092535,"median":-27.098554,"eighty":-25.818169,"marketCap":4708478107}],"updateTime":1757414623454},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02561\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2563722853","title":"Visen Pharmaceuticals Expands Supply Agreement with Ascendis Group for Broader Product Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2563722853","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563722853?lang=en_us&edition=fundamental","pubTime":"2025-08-31 20:17","pubTimestamp":1756642652,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals has announced a supplemental agreement to its existing Commercial Supply Framework Agreement with Ascendis Europe. This amendment, signed on August 29, 2025, allows VISEN HK and its subsidiaries to purchase drug packages, auto-injectors, and ancillary products from Ascendis A/S and its subsidiaries. The modification aims to enhance flexibility and resource allocation within the Ascendis Group, benefiting both parties involved. The announcement follows a previous circular issued on June 12, 2025, regarding the connected transactions under the original framework. Executive Director and CEO of Visen Pharmaceuticals, Mr. LU An-Bang, emphasized that aside from the disclosed changes, all other details of the agreement remain unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250831:nNDL3VPCbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2562070730","title":"VISEN Pharmaceuticals' H1 Loss Widens 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562070730","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562070730?lang=en_us&edition=fundamental","pubTime":"2025-08-28 14:02","pubTimestamp":1756360959,"startTime":"0","endTime":"0","summary":"VISEN Pharmaceuticals  reported 118 million yuan in attributable loss for the first half of 2025, widening by 41% from a loss 83.5 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.Loss per share was 1.18 yuan, compared with 0.89 yuan in the prior year.It came as the company, which debuted on the Hong Kong bourse in March, continues to develop its core product called lonapegsomatropin, a long-acting growth hormone for the treatment of pediatric growth hormone deficiency.In July, the company partnered with Anhui Anke Biotechnology  to jointly promote the drug in specific regions of China.Shares of the pharmaceutical company fell 1.1% in midday trade Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300009","BK0042","BK0060","BK0070","BK0239","BK1161","02561"],"gpt_icon":0},{"id":"2562067740","title":"BRIEF-Visen Pharmaceuticals Logs HY Loss RMB118 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562067740","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562067740?lang=en_us&edition=fundamental","pubTime":"2025-08-27 22:59","pubTimestamp":1756306755,"startTime":"0","endTime":"0","summary":"BRIEF-Visen Pharmaceuticals Logs HY Loss RMB118 MlnAug 27 (Reuters) - Visen Pharmaceuticals 2561.HK:HY LOSS RMB118 MILLIONFurther company coverage: 2561.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nFWN3UJ0FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2562174049","title":"Visen Pharmaceuticals Reports Increased Loss of RMB 118 Million for H1 2025; R&D and Administrative Expenses Rise Significantly","url":"https://stock-news.laohu8.com/highlight/detail?id=2562174049","media":"Reuters","labels":["executive","dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562174049?lang=en_us&edition=fundamental","pubTime":"2025-08-27 22:46","pubTimestamp":1756305998,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals Reports Increased Loss of RMB 118 Million for H1 2025; R&D and Administrative Expenses Rise Significantly. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visen Pharmaceuticals published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL9Cm74T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02561\",params:#limit:6,delay:false,,,undefined,":[]}}